- GSK ( NYSE: GSK ) Iqvia ( NYSE: IQV ) launched Vaccine Track, a platform to track vaccination data across the U.S.
- The companies said the platform will be for use by public health officials, industry leaders and medical professionals to strengthen vaccination data transparency, raise awareness and publicly share vaccination trends to help improve routine adult vaccinations.
- Vaccine Track will help users identify vaccination trends for adults above 19 years of age in the U.S. across multiple vaccines; scan immunization claims data nationally and sub-nationally across years; track trends based on 2019 pre-COVID-19 baseline vaccination uptake; and bring to light differences that exist based on demographics, such as age, gender, race and ethnicity, among others.
- The companies said the platform currently spans information from January 2019 to December 2021 and will be updated on a quarterly basis.
- "For the first time, Vaccine Track brings quarterly data tracking and trends together in a comprehensive platform for immunization partners, decision makers and stakeholders," said Judy Stewart, GSK senior vice president and head of U.S. Vaccines.
For further details see:
GSK, Iqvia launch Vaccine Track platform to highlight vaccine trends publicly in US